◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › TNXP

Tonix Pharmaceuticals Holding Corp. (TNXP) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-09

Tonix Pharmaceuticals Holding Corp. (TNXP) operates in the Biotechnology industry and is headquartered in Berkeley Heights, United States with about 142 employees. Its market capitalization is roughly $208 million. In the fiscal year ended 2025-12-31, TNXP reported $13M in revenue and ($124M) in net income.

Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States.

Interactive charts & full statements → Open the TNXP valuation workbench →

TNXP Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$13M$10M$8M$0M
Gross Profit$6M$2M$3M$0M
Operating Income (EBIT)($123M)($75M)($118M)($112M)
Net Income($124M)($130M)($117M)($110M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TNXP Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$7M$5M$3M$2M$2M
Gross Profit$5M$4M$2M($1M)$2M
Operating Income (EBIT)($42M)($48M)($32M)($27M)($15M)
Net Income($40M)($47M)($32M)($28M)($17M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TNXP Free Cash Flow History

TNXP Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$277M$163M$154M$226M
Total Liabilities$32M$23M$49M$18M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TNXP viewer.

Other Companies in Biotechnology

← TNONAll stocksTNYA →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.